Redefining the pathogenesis of Gestational Diabetes Mellitus: The cumulative impact of endocrine disrupting environmental chemicals in key metabolic pathways
{"title":"Redefining the pathogenesis of Gestational Diabetes Mellitus: The cumulative impact of endocrine disrupting environmental chemicals in key metabolic pathways","authors":"Mahesh Vallabi Aayush , Gopichandran Nikthesh , Dhanush Rajmohan , Charan Praneeth Ravindran , Ramasamy Vasantharekha , Swarnalingam Thangavelu , Barathi Seetharaman","doi":"10.1016/j.mehy.2025.111693","DOIUrl":null,"url":null,"abstract":"<div><div>Gestational Diabetes Mellitus (GDM) is a common pregnancy complication with a prevalence rate of 10–14 % in India. In GDM high blood glucose level and insulin resistance is observed. Several hormones secreted from placenta during pregnancy changes the metabolic state and interferes with insulin functions and blocks insulin and increases blood glucose level/hyperglycemia. Emerging evidence links GDM to environmental exposures, particularly endocrine-disrupting chemicals (EDCs) such as Bisphenol A (BPA), phthalates, parabens, and microplastics. These EDCs impair glucose metabolism and insulin signaling through oxidative stress, inflammation, hormonal interference, and pathway disruptions, including the hypothalamic-pituitary-thyroid (HPT) axis and PI3K-AKT signaling. This paper hypothesizes that frequent EDC exposure in pregnant women might trigger HPT axis thereby increasing insulin resistance and impair glucose homeostasis increasing the risk of GDM. Supporting evidence from mechanistic and epidemiological studies highlights the need for regulatory policies and early detection strategies. Validating this hypothesis could reshape GDM prevention and management by identifying therapeutic targets and minimizing EDC exposure.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"201 ","pages":"Article 111693"},"PeriodicalIF":0.8000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical hypotheses","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S030698772500132X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Gestational Diabetes Mellitus (GDM) is a common pregnancy complication with a prevalence rate of 10–14 % in India. In GDM high blood glucose level and insulin resistance is observed. Several hormones secreted from placenta during pregnancy changes the metabolic state and interferes with insulin functions and blocks insulin and increases blood glucose level/hyperglycemia. Emerging evidence links GDM to environmental exposures, particularly endocrine-disrupting chemicals (EDCs) such as Bisphenol A (BPA), phthalates, parabens, and microplastics. These EDCs impair glucose metabolism and insulin signaling through oxidative stress, inflammation, hormonal interference, and pathway disruptions, including the hypothalamic-pituitary-thyroid (HPT) axis and PI3K-AKT signaling. This paper hypothesizes that frequent EDC exposure in pregnant women might trigger HPT axis thereby increasing insulin resistance and impair glucose homeostasis increasing the risk of GDM. Supporting evidence from mechanistic and epidemiological studies highlights the need for regulatory policies and early detection strategies. Validating this hypothesis could reshape GDM prevention and management by identifying therapeutic targets and minimizing EDC exposure.
期刊介绍:
Medical Hypotheses is a forum for ideas in medicine and related biomedical sciences. It will publish interesting and important theoretical papers that foster the diversity and debate upon which the scientific process thrives. The Aims and Scope of Medical Hypotheses are no different now from what was proposed by the founder of the journal, the late Dr David Horrobin. In his introduction to the first issue of the Journal, he asks ''what sorts of papers will be published in Medical Hypotheses? and goes on to answer ''Medical Hypotheses will publish papers which describe theories, ideas which have a great deal of observational support and some hypotheses where experimental support is yet fragmentary''. (Horrobin DF, 1975 Ideas in Biomedical Science: Reasons for the foundation of Medical Hypotheses. Medical Hypotheses Volume 1, Issue 1, January-February 1975, Pages 1-2.). Medical Hypotheses was therefore launched, and still exists today, to give novel, radical new ideas and speculations in medicine open-minded consideration, opening the field to radical hypotheses which would be rejected by most conventional journals. Papers in Medical Hypotheses take a standard scientific form in terms of style, structure and referencing. The journal therefore constitutes a bridge between cutting-edge theory and the mainstream of medical and scientific communication, which ideas must eventually enter if they are to be critiqued and tested against observations.